Drugs Online |
 |
 | ||
|
Acivir DT Zovirax |
|
| ||
Drugs Online » Prescription Drugs 1 » Acivir DT Zovirax Aciclovir is used for: Treating chickenpox (varicella) or shingles (herpes zoster) and treating or suppressing genital herpes infections. Aciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection.Aciclovir will not cure herpes but it can lessen the symptoms of the infection. Acyclovir is used to treat infections caused by herpes viruses. Buy Acivir DT Zovirax and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About Acivir DT Zovirax: Product Type: Prescription Drugs 1 Acivir DT ( Zovirax Generic Aciclovir ) Acivir DT (Zovirax Generic Aciclovir) Zovirax Generic Aciclovir 200mg 400(4 x 100) Tablets 200mg 100 Tablets 200mg 200(2 x 100) Tablets 400mg 50 Tablets 400mg 100(2 x 50) Tablets 400mg 200(4 x 50) Tablets Zovirax Generic Aciclovir Acivir DT
View more Prescription Drugs 1 Drugs Online: From Gulf News: Runners should avoid prescription drugs. Statins may increase production of the enzyme creatine kinase, and hence heighten chances of muscle damage in athletes. Marathon running has increased in popularity over the past three decades, with participation in the United States rising from 25,000 runners in 1976 to nearly 470,000 in 2008. Many professional and recreational runners take prescription drugs, unaware of potential side-effects that affect runners in particular. One such class of drugs, called statins, which includes medicines such as Lipitor, Crestor and Pravachol, lowers blood cholesterol by inhibiting a cholesterol-producing enzyme and may even lower the risks of heart attack and further cardiovascular disease in a narrow category of patients. A new study forthcoming in the American Journal of Cardiology examined the effect of statins on creatine kinase (CK), an enzyme linked to muscle damage. Elevated levels of CK in the blood and muscle after exercise correlates with muscle damage. The study, conducted by Dr Beth Parker of the Henry Low Heart Centre at Connecticut's Hartford Hospital, is the first to measure CK levels in athletes taking statins after physical activity in a real-life environment rather than in a university laboratory.
| ||
